Captavis Biocare Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 9.00 Cr
as on 16-11-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.02 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Net Worth 66.23%
(FY 2023)
- Total Assets 475.18%
(FY 2023)
About Captavis Biocare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 9.00 Cr.
The company currently has active open charges totaling ₹26.02 Cr.
Dhirubhai Kanetiya, Pareshkumar Kanetiya, Vallabh Lakadia, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24290GJ2021PTC121485
- Company No.
121485
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Captavis Biocare?
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhirubhai Kanetiya  | Director | 24-Jul-2021 | Current |
| Pareshkumar Kanetiya | Director | 24-Jul-2021 | Current |
| Vallabh Lakadia | Director | 23-Mar-2021 | Current |
| Nisarg Lakadia | Director | 07-Jul-2021 | Current |
| Hardik Lakadia | Director | 07-Jul-2021 | Current |
| Prakashbhai Patel | Director | 24-Jul-2021 | Current |
Financial Performance of Captavis Biocare.
Captavis Biocare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 66.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Captavis Biocare?
In 2023, Captavis Biocare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maruti Spintex Private LimitedActive 14 years 4 monthsDhirubhai Kanetiya and Pareshkumar Kanetiya are mutual person
Maruti Texprocess India Private LimitedActive 4 years 7 daysDhirubhai Kanetiya and Pareshkumar Kanetiya are mutual person
Charges (Loans)
₹26.02 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 26.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jun 2022 | Others | ₹26.02 Cr | Open |
How Many Employees Work at Captavis Biocare?
Unlock and access historical data on people associated with Captavis Biocare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Captavis Biocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Captavis Biocare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
